Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis

Sofie Sølvsten Sørensen; Berit Jul Mosgaard

Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis

Sofie Sølvsten Sørensen, Berit Jul Mosgaard

Research output: Contribution to journal › Journal article › Research › peer-review

61 Citations (Scopus)

Abstract

The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.

Original language	English
Journal	Danish Medical Bulletin (Online)
Volume	58
Issue number	11
Pages (from-to)	A4331
ISSN	1603-9629
Publication status	Published - 2011

Cite this

@article{bc8e698270a249219e9f4fc518dcc485,

title = "Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis",

abstract = "The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.",

author = "S{\o}rensen, {Sofie S{\o}lvsten} and Mosgaard, {Berit Jul}",

year = "2011",

language = "English",

volume = "58",

pages = "A4331",

journal = "Danish Medical Bulletin (Online)",

issn = "1603-9629",

publisher = "Almindelige Danske Laegeforening",

number = "11",

}

TY - JOUR

T1 - Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis

AU - Sørensen, Sofie Sølvsten

AU - Mosgaard, Berit Jul

PY - 2011

Y1 - 2011

N2 - The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.

AB - The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.

M3 - Journal article

SN - 1603-9629

VL - 58

SP - A4331

JO - Danish Medical Bulletin (Online)

JF - Danish Medical Bulletin (Online)

IS - 11

ER -